Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / adicet bio microcap with a high risk to reward ratio

IMTX - Adicet Bio: Microcap With A High Risk To Reward Ratio

Immatics N.V.

2024-05-23 11:06:03 ET

Summary

  • Adicet Bio is a biotech company focused on developing off-the-shelf cell therapies for cancer and autoimmune diseases.
  • They are currently conducting a phase 1 trial for their pilot cell therapy, ADI-001, targeting B-cell non-Hodgkin's lymphomas.
  • Adicet has a strong financial position with $247.6 million in cash and equivalents, providing them with 8-9 quarters of cash on hand.

Topline Summary

For further details see:

Adicet Bio: Microcap With A High Risk To Reward Ratio
Stock Information
Company Name: Immatics N.V.
Stock Symbol: IMTX
Market: NYSE
Menu
IMTX IMTX Quote IMTX Short IMTX News IMTX Articles IMTX Message Board
Get IMTX Alerts

News, Short Squeeze, Breakout and More Instantly...